Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged patent licensing · clear
Public IP licensing companies (PIPCOs) are very much alive and some company shares are doing surprisingly well, despite increased obstacles to patent licensing. PIPX reported a 20.4% gain for the 3Q vs. just 3.3% for the S&P 500 . It was the PIPX’s…
Dilligent Patexia users may have noticed a new type of contest recently appear on our site: “commercial use” or “licensing” searches. In fact, we just closed our first search of this kind (investigating a particular antibacterial…
Developing drugs to fight cancer, the fourth most prevalent cause of human deaths worldwide, is a mission beyond reproach. That the U.S. government has allocated a significant portion of funds and bright minds towards the cause is still more commendable.…
